As of 2:30 PM on the 6th, Komipharm is trading at 13,500 KRW, up 2.66% from the previous day. This marks a 6.3% increase compared to December 22. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners have a net purchase of 16,575 shares of Komipharm, while institutions have a net sale of 2,000 shares, according to provisional data. Over the past five days, individual investors have net sold 67,393 shares, while foreigners and institutions have net bought 100,529 shares and net sold 25,442 shares, respectively.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing